What Is Bradycardia?

Bradycardia is a cardiac rhythm disturbance defined by a resting heart rate below 60 beats per minute in adults. It is the counterpart to tachycardia within the study of heart rate regulation, and it describes a rate rather than a single disease: many distinct electrical and metabolic faults converge on the same slow rhythm. A low rate is not automatically pathological, since trained endurance athletes and healthy sleeping adults routinely record rates in the 40s with no symptoms at all. Bradycardia becomes clinically significant when the slowed rate stops supporting adequate cardiac output, producing fatigue, dizziness, exercise intolerance, or syncope.

For biomedical engineering the condition presents two connected problems. The first is detection: the rhythm has to be recognized reliably from an electrocardiogram or a peripheral pulse signal, in noisy conditions and often without a clinician present. The second is therapy, because symptomatic bradycardia is the principal indication for implantable cardiac pacing and has driven device design since the first fully implanted pacemaker in 1958.

Electrophysiological Origins

The sinoatrial node is the heart's default pacemaker, and its intrinsic firing rate of roughly 60 to 100 beats per minute sets the normal sinus rhythm. Bradycardia arises either from a failure of impulse formation at that node or from a failure of impulse conduction below it. Sinus node dysfunction, historically called sick sinus syndrome, covers sinus arrest, sinoatrial exit block, and chronotropic incompetence, in which the node cannot accelerate appropriately with exercise. Conduction failure produces the atrioventricular blocks, graded from a prolonged PR interval in first-degree block through to complete dissociation of atrial and ventricular activity in third-degree block, a spectrum surveyed in a clinical review of bradycardias and atrioventricular conduction block. Reversible external causes matter just as much in practice: high vagal tone, hypothyroidism, hyperkalemia, hypothermia, obstructive sleep apnea, and drugs including beta blockers, calcium channel blockers, and digoxin.

Detection and Monitoring

Automated detection begins with QRS complex identification, then converts successive RR intervals into an instantaneous or averaged rate that is compared against a threshold. Diagnosis in the clinic still rests on visualizing a sinus rhythm slower than 60 beats per minute on a standard 12-lead trace, the criterion set out in a StatPearls review of sinus bradycardia. Continuous monitoring is harder. Motion artifact, low-amplitude QRS complexes, and lead detachment all cause missed beats, and a missed beat doubles the apparent RR interval, so bradycardia and asystole alarms are among the most common false alarms in intensive care. Algorithm developers benchmark against annotated recordings such as the MIT-BIH Arrhythmia Database hosted on PhysioNet. Ambulatory Holter monitors, insertable loop recorders, and photoplethysmographic wearables extend surveillance across weeks or years, at the cost of weaker signal quality.

Pacing and Device Therapy

When bradycardia is symptomatic and irreversible, a permanent pacemaker restores an adequate rate by delivering timed stimuli through transvenous leads placed in the right atrium, right ventricle, or both. Programming follows the generic pacemaker code, where modes such as VVI and DDD specify the chambers paced, the chambers sensed, and the device response to a sensed event. Patients with chronotropic incompetence receive rate-responsive pacing, in which an accelerometer or a minute-ventilation sensor raises the pacing rate during activity. More recent designs include leadless pacemakers implanted directly in the ventricle and conduction system pacing that captures the His bundle or the left bundle branch area to preserve a physiological activation sequence. Guidance on the arrhythmia types that warrant such intervention is maintained by the National Heart, Lung, and Blood Institute.

Applications

Bradycardia is a working concern across a range of engineering and clinical disciplines, including:

• Cardiac rhythm management device design, from lead materials to pacing algorithms
• Intensive care monitoring and alarm-reduction research
• Wearable and consumer heart rate sensing
• Neonatal intensive care, where apnea-related bradycardia is a monitored endpoint
• Sports physiology and pre-participation athlete screening
• Cardiac safety telemetry in pharmaceutical clinical trials